MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
21 août 2019 20h13 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations concerning its...